Literature DB >> 15623601

Characterization of gastrin-induced proangiogenic effects in vivo in orthotopic U373 experimental human glioblastomas and in vitro in human umbilical vein endothelial cells.

Florence Lefranc1, Tatjana Mijatovic, Véronique Mathieu, Sandrine Rorive, Christine Decaestecker, Olivier Debeir, Jacques Brotchi, Philippe Van Ham, Isabelle Salmon, Robert Kiss.   

Abstract

PURPOSE: This study aims to investigate the role of gastrin-17 (G17) on angiogenesis features in gliomas both in vitro and in vivo. EXPERIMENTAL
DESIGN: The influences of G17 and G17 receptor antagonists were characterized in vitro in terms of angiogenesis on human umbilical vein endothelial cell (HUVEC) tubulogenesis processes on Matrigel and in vivo with respect to U373 orthotopic glioma xenografts. The influence of phosphatidylinositol 3'-kinase, protein kinase C, and nuclear factor-kappaB inhibitors was characterized in vitro on G17-mediated HUVEC tubulogenesis. G17-mediated release of interleukin (IL)-8 from HUVECs and G17-induced modifications in nuclear factor-kappaB DNA binding activity were characterized by means of specific enzyme-linked immunosorbent assays. The influence of G17 on E- and P-selectin expression was determined by means of computer-assisted microscopy, whereas the influence of E- and P-selectin on HUVEC migration was approached by means of antisense oligonucleotides. The chemotactic influence of G17 and IL-8 on HUVEC migration was characterized by means of computer-assisted videomicroscopy with Dunn chambers.
RESULTS: Messenger RNAs for cholecystokinin (CCK)A, CCKB, and CCKC receptors were present in HUVECs and microvessels dissected from a human glioblastoma. Whereas G17 significantly increased the levels of angiogenesis in vivo in the U373 experimental glioma model and in vitro in the HUVECs, the CCKB receptor antagonist L365,260 significantly counteracted the G17-mediated proangiogenic effects. G17 chemoattracted HUVECs, whereas IL-8 failed to do so. IL-8 receptor alpha (CXCR1) and IL-8 receptor beta (CXCR2) mRNAs were not detected in these endothelial cells. Gastrin significantly (but only transiently) decreased the level of expression of E-selectin, but not P-selectin, whereas IL-8 increased the expression of E-selectin. Specific antisense oligonucleotides against E- and P-selectin significantly decreased HUVEC tubulogenesis processes in vitro on Matrigel.
CONCLUSIONS: The present study shows that gastrin has marked proangiogenic effects in vivo on experimental gliomas and in vitro on HUVECs. This effect depends in part on the level of E-selectin activation, but not on IL-8 expression/release by HUVECs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15623601     DOI: 10.1158/1078-0432.CCR-04-0343

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  15 in total

1.  Impaired orthotopic glioma growth and vascularization in transgenic mouse models of Alzheimer's disease.

Authors:  Daniel Paris; Nowel Ganey; Magdalena Banasiak; Vincent Laporte; Nikunj Patel; Myles Mullan; Susan F Murphy; Gi-Taek Yee; Corbin Bachmeier; Christopher Ganey; David Beaulieu-Abdelahad; Venkatarajan S Mathura; Steven Brem; Michael Mullan
Journal:  J Neurosci       Date:  2010-08-25       Impact factor: 6.167

2.  A network map of the gastrin signaling pathway.

Authors:  Yashwanth Subbannayya; Kumari Anuja; Jayshree Advani; Urmesh Kumar Ojha; Vishalakshi Nanjappa; Bijesh George; Avinash Sonawane; Rekha V Kumar; Girija Ramaswamy; Akhilesh Pandey; B L Somani; Rajesh Raju
Journal:  J Cell Commun Signal       Date:  2014-03-02       Impact factor: 5.782

3.  Gastrin exerts pleiotropic effects on human melanoma cell biology.

Authors:  Véronique Mathieu; Tatjana Mijatovic; Marc van Damme; Robert Kiss
Journal:  Neoplasia       Date:  2005-10       Impact factor: 5.715

4.  Combining bevacizumab with temozolomide increases the antitumor efficacy of temozolomide in a human glioblastoma orthotopic xenograft model.

Authors:  Véronique Mathieu; Nancy De Nève; Marie Le Mercier; Janique Dewelle; Jean-François Gaussin; Mischael Dehoux; Robert Kiss; Florence Lefranc
Journal:  Neoplasia       Date:  2008-12       Impact factor: 5.715

5.  UNBS5162, a novel naphthalimide that decreases CXCL chemokine expression in experimental prostate cancers.

Authors:  Tatjana Mijatovic; Tina Mahieu; Céline Bruyère; Nancy De Nève; Janique Dewelle; Gentiane Simon; Mischaël J M Dehoux; Ellen van der Aar; Benjamin Haibe-Kains; Gianluca Bontempi; Christine Decaestecker; Eric Van Quaquebeke; Francis Darro; Robert Kiss
Journal:  Neoplasia       Date:  2008-06       Impact factor: 5.715

6.  Anti-proliferative effect of the gastrin-release peptide receptor antagonist RC-3095 plus temozolomide in experimental glioblastoma models.

Authors:  Marianne Schrader de Oliveira; Giovana Cechim; Elisandra Braganhol; Daniel Garcia Santos; Luise Meurer; Cláudio Galvão de Castro; Algemir Lunardi Brunetto; Gilberto Schwartsmann; Gilberto Schwarstmann; Ana Maria Oliveira Battastini; Guido Lenz; Rafael Roesler
Journal:  J Neurooncol       Date:  2009-01-08       Impact factor: 4.130

7.  4-IBP, a sigma1 receptor agonist, decreases the migration of human cancer cells, including glioblastoma cells, in vitro and sensitizes them in vitro and in vivo to cytotoxic insults of proapoptotic and proautophagic drugs.

Authors:  Véronique Mégalizzi; Véronique Mathieu; Tatjana Mijatovic; Philippe Gailly; Olivier Debeir; Nancy De Neve; Marc Van Damme; Gianluca Bontempi; Benjamin Haibe-Kains; Christine Decaestecker; Yasuko Kondo; Robert Kiss; Florence Lefranc
Journal:  Neoplasia       Date:  2007-05       Impact factor: 5.715

8.  Dynamics of regulatory networks in gastrin-treated adenocarcinoma cells.

Authors:  Naresh Doni Jayavelu; Nadav Bar
Journal:  PLoS One       Date:  2014-01-08       Impact factor: 3.240

9.  Galectin-1 is implicated in the protein kinase C epsilon/vimentin-controlled trafficking of integrin-beta1 in glioblastoma cells.

Authors:  Shannon Fortin; Marie Le Mercier; Isabelle Camby; Sabine Spiegl-Kreinecker; Walter Berger; Florence Lefranc; Robert Kiss
Journal:  Brain Pathol       Date:  2009-10-08       Impact factor: 6.508

10.  The sodium pump alpha1 sub-unit: a disease progression-related target for metastatic melanoma treatment.

Authors:  Véronique Mathieu; Christine Pirker; Elisabeth Martin de Lassalle; Mathieu Vernier; Tatjana Mijatovic; Nancy DeNeve; Jean-François Gaussin; Mischael Dehoux; Florence Lefranc; Walter Berger; Robert Kiss
Journal:  J Cell Mol Med       Date:  2009-02-20       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.